After pilot project, Takeda inks $500M pact to tap into a Kevan Shokat protégé’s covalent small molecule fishing platform

As new technologies open up new avenues toward targets widely considered undruggable by small molecules, Takeda is taking a chance on a low-profile drug discovery player with promises of up to $500 million in biobucks.

Ping Cao

Over the next two years, Sunnyvale, CA-based BridGene will...

Click to view original post